Views | |
---|---|
Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 152 |
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 1 | 2 | 1 | 1 | 1 | 1 | 4 |
Views | |
---|---|
2021_Yu_etal.pdf | 54 |